7Baggers
 Published on: 2025-11-16 06:50:54  newser.com Sun, 16 Nov 2025 12:50:54 GMT
 moleculin biotech bets big on new cancer drug trials  Finimize Sun, 16 Nov 2025 01:54:57 GMT
 Moleculin Biotech Bets Big On New Cancer Drug Trials  Finimize Sat, 15 Nov 2025 12:07:28 GMT
 Moleculin Biotech Reports Increased Loss Amid Ongoing Trials  TipRanks Fri, 14 Nov 2025 04:19:18 GMT
 moleculin reports 60% enrollment in pivotal aml treatment trial by investing.com  Investing.com Nigeria Fri, 14 Nov 2025 03:05:49 GMT
 Moleculin Biotech (MBRX) Nears Key Milestone in Annamycin Study  GuruFocus Thu, 13 Nov 2025 14:36:21 GMT
 Moleculin Biotech Advances Annamycin Phase 2B/3 Study  TipRanks Thu, 13 Nov 2025 14:15:00 GMT
 Moleculin reports 60% enrollment in pivotal AML treatment trial  Investing.com Thu, 13 Nov 2025 14:11:14 GMT
 Moleculin Biotech Partners with UNC for Cancer Research  TipRanks Wed, 12 Nov 2025 14:33:23 GMT
 published on: 2025-11-06 09:33:38  newser.com Thu, 06 Nov 2025 15:33:38 GMT
 published on: 2025-11-06 06:02:39  newser.com Thu, 06 Nov 2025 12:02:39 GMT
 published on: 2025-11-06 03:11:14  Fundação Cultural do Pará Thu, 06 Nov 2025 06:11:14 GMT
 published on: 2025-11-05 15:52:06  fcp.pa.gov.br Wed, 05 Nov 2025 18:52:06 GMT
 published on: 2025-11-05 06:01:03  newser.com Wed, 05 Nov 2025 12:01:03 GMT
 published on: 2025-11-02 06:40:39  newser.com Sun, 02 Nov 2025 11:40:39 GMT
 published on: 2025-11-02 01:09:40  newser.com Sun, 02 Nov 2025 06:09:40 GMT
 published on: 2025-11-02 00:55:06  newser.com Sun, 02 Nov 2025 05:55:06 GMT
 moleculin biotech, inc. (mbrx) analyst insights, price targets & recommendations  Yahoo! Finance Canada Sun, 02 Nov 2025 02:30:51 GMT
 ebitda per share of moleculin biotech, inc. – ber:mol  TradingView Sat, 01 Nov 2025 15:58:46 GMT
 published on: 2025-11-01 06:01:51  newser.com Sat, 01 Nov 2025 11:01:51 GMT
 published on: 2025-10-31 01:25:46  newser.com Fri, 31 Oct 2025 06:25:46 GMT
 moleculin presents annamycin leukemia study at madrid conference by investing.com  Investing.com South Africa Thu, 30 Oct 2025 17:21:37 GMT
 Moleculin to Highlight its Ongoing Phase 3 Acute Myeloid  GlobeNewswire Thu, 30 Oct 2025 07:00:00 GMT
 Moleculin Biotech Releases New Corporate Presentation  TipRanks Thu, 30 Oct 2025 07:00:00 GMT
 mbrx - moleculin biotec latest stock news & market updates  Stock Titan Thu, 30 Oct 2025 07:00:00 GMT

Moleculin Biotech, Inc
(NASDAQ:MBRX) 

MBRX stock logo

Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of oncology drug candidates for the treatment of highly resistant tumors and viruses in the United States. Its lead drug candidate is Annamycin that is in Phase 1/2 studies for the treatment of relapsed or r...

Founded: 2015
Full Time Employees: 11
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends